A prognostic nomogram for colorectal cancer liver metastases after percutaneous thermal ablation

References

• Mahasneh A, Al-Shaheri F, Jamal E. (2017). Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: current updates. Exp Mol Pathol 102:475–83.
   PubMed Web of Science ®Google Scholar
• Verma M, Kumar V. (2017). Epigenetic biomarkers in colorectal cancer. Mol Diagn Ther 21:153–65.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–86.
   PubMed Web of Science ®Google Scholar
• Millikan KW, Staren ED, Doolas A. (1997). Invasive therapy of metastatic colorectal cancer to the liver. Surg Clin North Am 77:27–48.
   PubMed Web of Science ®Google Scholar
• Wagner JS, Adson MA, Van Heerden JA, et al. (1984). The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 199:502–8.
   PubMed Web of Science ®Google Scholar
• Bozzetti F, Doci R, Bignami P, et al. (1987). Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg 205:264–70.
   PubMed Web of Science ®Google Scholar
• Stangl R, Altendorf-Hofmann A, Charnley RM, et al. (1994). Factors influencing the natural history of colorectal liver metastases. Lancet 343:1405–10.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Cervantes A, Nordlinger B, et al. (2014). Metastatic colorectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 25:iii1–9.
   PubMed Web of Science ®Google Scholar
• Huang L, Li TJ, Zhang JW, et al. (2014). Neoadjuvant chemotherapy followed by surgery versus surgery alone for colorectal cancer: meta-analysis of randomized controlled trials. Medicine 93:e231.
   PubMed Web of Science ®Google Scholar
• Ji JH, Park SH, Lee J, et al. (2013). Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis. Cancer Chemother Pharmacol 72:223–30.
   PubMed Web of Science ®Google Scholar
• Kim JY, Kim JS, Baek MJ, et al. (2013). Prospective multicenter phase II clinical trial of FOLFIRI chemotherapy as a neoadjuvant treatment for colorectal cancer with multiple liver metastases. J Korean Surg Soc 85:154–60.
   PubMedGoogle Scholar
• Kataoka M, Kanda M, Ishigure K, et al. (2017). The COMET open-label phase II study of neoadjuvant FOLFOX or XELOX treatment combined with molecular targeting monoclonal antibodies in patients with resectable liver metastasis of colorectal cancer. Ann Surg Oncol 24:546–53.
   PubMed Web of Science ®Google Scholar
• Nasti G, Piccirillo MC, Izzo F, et al. (2013). Neoadjuvant FOLFIRI + bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial. Br J Cancer 108:1566–70.
   PubMed Web of Science ®Google Scholar
• Cirocchi R, Trastulli S, Boselli C, et al. (2012). Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev 6:CD006317.
   PubMed Web of Science ®Google Scholar
• Adam R, Wicherts DA, de Haas RJ, et al. (2009). Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol 27:1829–35.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lim HK, Rhim H, et al. (2014). Ablation of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 28:897–908.
   PubMed Web of Science ®Google Scholar
• Li W, Wang Y, Gao W, et al. (2016). Combination of transcatheter arterial chemoembolization and CT-guided percutaneous segment ablation for hepatocellular carcinoma therapy: a retrospective study. Medicine 95:e5422.
   PubMed Web of Science ®Google Scholar
• Zheng JS, Long J, Sun B, et al. (2014). Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: extending the indication for ablation? Clin Radiol 69:e253–63.
   PubMed Web of Science ®Google Scholar
• Li JJ, Zheng JS, Cui SC, et al. (2015). C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma. World J Gastroenterol 21:3035–40.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Kimura T, Kita R, et al. (2013). Radiofrequency ablation for hepatocellular carcinoma. Int J Hyperthermia 29:558–68.
   PubMed Web of Science ®Google Scholar
• Poch FG, Rieder C, Ballhausen H, et al. (2016). The vascular cooling effect in hepatic multipolar radiofrequency ablation leads to incomplete ablation ex vivo. Int J Hyperthermia 32:749–56.
   PubMed Web of Science ®Google Scholar
• Poulou LS, Botsa E, Thanou I, et al. (2015). Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Hepatol 7:1054–63.
   PubMed Web of Science ®Google Scholar
• Guo W, He X, Li Z, et al. (2015). Combination of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) vs. surgical resection (SR) on survival outcome of early hepatocellular carcinoma: a meta-analysis. Hepato-gastroenterology 62:710–14.
   PubMedGoogle Scholar
• Hamada A, Yamakado K, Nakatsuka A, et al. (2012). Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates. Jpn J Radiol 30:567–74.
   PubMed Web of Science ®Google Scholar
• Solbiati L, Ahmed M, Cova L, et al. (2012). Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology 265:958–68.
   PubMed Web of Science ®Google Scholar
• Livraghi T, Solbiati L, Meloni MF, et al. (2003). Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441–51.
   PubMed Web of Science ®Google Scholar
• Lang BH, Wong CK. (2015). Validation and comparison of nomograms in predicting disease-specific survival for papillary thyroid carcinoma. World J Surg 39:1951–8.
   PubMed Web of Science ®Google Scholar
• Al-Daghmin A, English S, Kauffman EC, et al. (2014). External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder. BJU Int 114:253–60.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li J, Xia Y, et al. (2013). Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 31:1188–95.
   PubMed Web of Science ®Google Scholar
• Kattan MW, Gonen M, Jarnagin WR, et al. (2008). A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg 247:282–7.
   PubMed Web of Science ®Google Scholar
• Fendler WP, Ilhan H, Paprottka PM, et al. (2015). Nomogram including pretherapeutic parameters for prediction of survival after SIRT of hepatic metastases from colorectal cancer. Eur Radiol 25:2693–700.
   PubMed Web of Science ®Google Scholar
• Gaba RC, Lewandowski RJ, Hickey R, et al. (2016). Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol 27:457–73.
   PubMed Web of Science ®Google Scholar
• Cardella JF, Kundu S, Miller DL, et al. (2009). Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol 20:S189–S91.
   PubMed Web of Science ®Google Scholar
• Harrell FE Jr, Lee KL, Mark DB. (1996). Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–87.
   PubMed Web of Science ®Google Scholar
• Harrell FE Jr. (2013). rms: regression modeling strategies. R package version 4.0-0. Computer software. Available from: http://CRAN.R-project.org/package=rms [last accessed 10 Mar 2017].
   Google Scholar
• Harrell FE Jr. (2013). Hmisc: Harrell miscellaneous. R package version 3.12-2. Computer software. Available from: http://CRAN.R-project.org/package=Hmisc [last accessed 10 Mar 2017].
   Google Scholar
• Long J, Zheng JS, Sun B, et al. (2016). Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study. Hepatol Int 10:175–84.
   PubMed Web of Science ®Google Scholar
• Liu M, Huang GL, Xu M, et al. (2017). Percutaneous thermal ablation for the treatment of colorectal liver metastases and hepatocellular carcinoma: a comparison of local therapeutic efficacy. Int J Hyperthermia 33:446–53.
   PubMed Web of Science ®Google Scholar
• Amabile C, Ahmed M, Solbiati L, et al. (2017). Microwave ablation of primary and secondary liver tumours: ex vivo, in vivo, and clinical characterisation. Int J Hyperthermia 33:34–42.
   PubMed Web of Science ®Google Scholar
• Brentnall AR, Cuzick J. (2016). Use of the concordance index for predictors of censored survival data. Stat Methods in Med Res 25:962280216680245.
   PubMed Web of Science ®Google Scholar
• De Groote K, Prenen H. (2015). Intrahepatic therapy for liver-dominant metastatic colorectal cancer. World J Gastrointest Oncol 7:148–52.
   PubMed Web of Science ®Google Scholar
• Gruber-Rouh T, Naguib NN, Eichler K, et al. (2014). Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period. Int J Cancer 134:1225–31.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Dommermuth A, Heinle B, et al. (2014). Colorectal cancer liver metastases: long-term survival and progression-free survival after thermal ablation using magnetic resonance-guided laser-induced interstitial thermotherapy in 594 patients: analysis of prognostic factors. Invest Radiol 49:48–56.
   PubMed Web of Science ®Google Scholar